参考文献/References:
[1] 杨彦,潘志兰,张志敏.多发性骨髓瘤患者骨髓细胞周期素D1、D3、p21的表达及与预后的相关性研究[J].微循环学杂志,2021,31(3):58-62.
[2] 王卫国,冯玉虎,许凌云,等.多发性骨髓瘤患者CD200的表达及与预后的关系[J].现代肿瘤医学,2021,29(23):4205-4208.
[3] 陈黎.来那度胺联合硼替佐米治疗多发性骨髓瘤的疗效及对免疫相关细胞因子含量的影响[J].临床研究,2021,29(4):53-54.
[4] ZHANG W,CAO L,LIU X,et al.High expression of CHML predicts poor prognosis of multiple myeloma[J].J Cancer,2019,10(24):6048-6056.
[5] 徐玉红,张慧雅,郑伟平,等.miR-369-3p和COL11A1对卵巢癌细胞增殖迁移及侵袭的影响[J].中国妇幼保健,2021,36(18):4327-4331.
[6] ZHENG X,LIU X,ZHENG H,et al.Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma[J].Int Immunopharmacol,2021,90(8):106982.
[7] 中国多发性骨髓瘤工作组.中国多发性骨髓瘤诊治指南[J].中华内科杂志,2008,47(10):869-872.
[8] XIA B,WANG X,YANG R,et al.Epstein-Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma[J].Biosci Rep,2019,39(10):BSR20190284.
[9] 贺冠强,郭敏,索晓慧,等.lncRNA TUG1和PCAT-1表达水平与多发性骨髓瘤预后的关系及其诊断价值分析[J].国际检验医学杂志,2021,42(2):171-176.
[10] 范丹,肖方,及月茹,等.自体造血干细胞移植治疗多发性骨髓瘤疗效观察[J].海南医学,2021,32(20):2615-2618.
[11] 宁雪琴,魏小磊,郭绪涛,等.自体造血干细胞移植可改善多发性骨髓瘤患者的临床状态[J].南方医科大学学报,2021,41(9):1420-1425.
[12] ZHANG W,ZHANG Y,YANG Z,et al.High expression of UBE2T predicts poor prognosis and survival in multiple myeloma[J].Cancer Gene Ther,2019,26(11/12):347-355.
[13] 刘雪影,许良璧,李大欢,等.COL11A1在消化系统肿瘤中的研究进展[J].中华胃肠内镜电子杂志,2021,8(1):42-45.
[14] LI A,LI J,LIN J,et al.COL11A1 is overexpressed in gastric cancer tissues and regulates proliferation,migration and invasion of HGC-27 gastric cancer cells in vitro[J].Oncol Rep,2017,37(1):333-340.
[15] 穆速,李俊江,刘成远,等.COL11A1在结直肠癌组织的表达及其对其增殖、迁移和侵袭能力的影响[J].中华实验外科杂志,2021,38(6):1090-1092.
[16] 王霄飞,王梦扬,焦林杰,等.α1-Ⅺ型胶原蛋白基因突变对胃癌患者预后的影响及机制研究[J].中国现代普通外科进展,2021,24(8):630-639.
[17] 冯晓杰,李雷.干扰COL11A1基因表达对人卵巢癌细胞侵袭及耐药性影响[J].中华肿瘤防治杂志,2019,26(13):908-916.